Мультифокальный остеонекроз как последствие новой коронавирусной инфекции

 Влияние перенесенной коронавирусной инфекции на опорно-двигательный аппарат до сих пор  остается актуальной проблемой. В постковидном  периоде могут возникать артралгии, миалгии,  поствирусный артрит, аутоиммунные нарушения, а также остеонекроз. В данной статье рассмотрен  случай дебюта мультифокального остеонекроза  после перенесенной коронавирусной инфекции. 

1. Cipollaro L, Giordano L, Padulo J, Oliva F, Maffulli N. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. J Orthop Surg. 2020;15(1):178. doi: 10.1186/s13018-020-01702-w

2. Agarwala SR, Vijayvargiya M, Pandey P. Avascular necrosis as a part of ‘long COVID-19. BMJ Case Rep. 2021;14(7):e242101. doi: 10.1136/bcr-2021-242101

3. Bagaria V. Usual and unusual musculoskeletal sequalae of COVID 19! Indian J Orthop. 2021;55(S2):518-519. doi: 10.1007/s43465-021-00412-7

4. Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, thrombosis, kidney failure, and diabetes: Is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J Clin Med. 2020;9(5):1417. doi: 10.3390/jcm9051417

5. Escher R, Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020;190:62. doi: 10.1016/j.thromres.2020.04.014

6. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5

7. Quinaglia T, Shabani M, Breder I, Silber HA, Lima JAC, Sposito AC. Coronavirus disease-19: The multi-level, multi-faceted vasculopathy. Atherosclerosis. 2021;322:39-50. doi: 10.1016/j.atherosclerosis.2021.02.009

8. Bernard I, Limonta D, Mahal L, Hobman TC. Endothelium infection and dysregulation by SARS-CoV-2: Evidence and caveats in COVID-19. Viruses. 2020;13(1):29. doi: 10.3390/v13010029

9. Veyre F, Poulain-Veyre C, Esparcieux A, Monsarrat N, Aouifi A, Lapeze J, et al. Femoral arterial thrombosis in a young adult after nonsevere COVID-19. Ann Vasc Surg. 2020;69:85-88. doi: 10.1016/j.avsg.2020.07.013

10. Huertas A, Montani D, Savale L, Pichon J, Tu L, Parent F, et al. Endothelial cell dysfunction: A major player in SARSCoV-2 infection (COVID-19)? Eur Respir J. 2020;56(1):2001634. doi: 10.1183/13993003.01634-2020

11. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002;3(6):889-901. doi: 10.1016/s1534-5807(02)00369-6

12. Hasan LK, Deadwiler B, Haratian A, Bolia IK, Weber AE, Petrigliano FA. Effects of COVID-19 on the musculoskeletal system: Clinician’s guide. Orthop Res Rev. 2021;13:141-50. doi: 10.2147/ORR.S321884

13. Obitsu S, Ahmed N, Nishitsuji H, Hasegawa A, Nakahama K, Morita I, et al. Potential enhancement of osteoclastogenesis by severe acute respiratory syndrome coronavirus 3a/X1 protein. Arch Virol. 2009;154(9):1457-1464. doi: 10.1007/s00705-009-0472-z

14. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998;102(2):274-282. doi: 10.1172/JCI2799

15. O’Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, et al. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology. 2004;145(4):1835-1841. doi: 10.1210/en.2003-0990

16. Weinstein RS, Chen J-R, Powers CC, Stewart SA, Landes RD, Bellido T, et al. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest. 2002;109(8):1041-1048. doi: 10.1172/JCI14538

17. Weinstein RS, Wan C, Liu Q, Wang Y, Almeida M, O’Brien CA, et al. Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell. 2010;9(2):147-161. doi: 10.1111/j.1474-9726.2009.00545.x

18. Sen R. Management of avascular necrosis of femoral head at precollapse stage. Indian J Orthop. 2009;43(1):6. doi: 10.4103/0019-5413.45318

19. Shetty GM. Double trouble – COVID-19 and the widespread use of corticosteroids: Are we staring at an osteonecrosis epidemic? Indian J Orthop. 2022;56(2):226-236. doi: 10.1007/s43465-021-00546-8

20. Pijnenburg L, Felten R, Javier R-M. Ostéonécroses aseptiques, une revue générale des ostéonécroses de la hanche, et au-delà. Rev Médecine Interne. 2020;41(1):27-36. doi: 10.1016/j.revmed.2019.10.332

21. Zhang N-F, Li ZR, Wei H-Y, Liu Z-H, Hernigou P. Steroidinduced osteonecrosis: The number of lesions is related to the dosage. J Bone Joint Surg Br. 2008;90-B(9):1239-1243. doi: 10.1302/0301-620X.90B9.20056

22. Aaron RK, Voisinet A, Racine J, Ali Y, Feller ER. Corticosteroidassociated avascular necrosis: dose relationships and early diagnosis: Ann N Y Acad Sci. 2011;1240(1):38-46. doi: 10.1111/j.1749-6632.2011.06218.x

23. Guo KJ, Zhao FC, Guo Y, Li FL, Zhu L, Zheng W. The influence of age, gender and treatment with steroids on the incidence of osteonecrosis of the femoral head during the management of severe acute respiratory syndrome: A retrospective study. Bone Jt J. 2014;96-B(2):259-262. doi: 10.1302/0301-620X.96B2.31935

24. Zhang B, Zhang S. Corticosteroid-induced osteonecrosis in COVID-19: A call for caution. J Bone Miner Res. 2020;35(9): 1828-1829. doi: 10.1002/jbmr.4136

25. McKee MD, Waddell JP, Kudo PA, Schemitsch EH, Richards RR. Osteonecrosis of the femoral head in men following short-course corticosteroid therapy: A report of 15 cases. CMAJ Can Med Assoc J. 2001;164(2):205-206.

26. Gangji V, Soyfoo MS, Heuschling A, Afzali V, Moreno-Reyes R, Rasschaert J, et al. Non traumatic osteonecrosis of the femoral head is associated with low bone mass. Bone. 2018;107:88-92. doi: 10.1016/j.bone.2017.11.005

27. Угнивенко ВИ. Асептический некроз головки бедренной кости URL: http://www.rusmedserv.com/orthopaedics/necr.htm (Accessed: 22nd March 2022).

28. Petek D, Hannouche D, Suva D. Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment. EFORT Open Rev. 2019;4(3):85-97. doi: 10.1302/2058-5241.4.180036

29. Bone Circulation and Osteonecrosis Professional Committee Shockwave Medical Specialty Committee of Chinese Research Hospital Association null. [Expert consensus on prevention and treatment strategies for osteonecrosis of femoral head during the prevention and control of novel coronavirus pneumonia (2020)]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi Zhongguo Xiufu Chongjian Waike Zazhi. 2020;34(8):1031-1035. doi: 10.7507/1002-1892.202003068

30. Шостак НА, Клименко АА, Демидова НА, Андрияшкна ДЮ, Ратьев АП, Чирков АВ, и др. Остеонекроз головки бедренной кости, не связанный с травмой: хирургические и консервативные методы лечения (часть 2). Лечебное дело. 2021;(4):4-16. doi: 10.24412/2071-5315-2021-12387

31. Osmani F, Thakkar S, Vigdorchik J. The utility of conservative treatment modalities in the management of osteonecrosis. Bull Hosp Jt Dis. 2017;75(3):186-192.

32. Асептический некроз костей (остеонекроз). Клинические рекомендации. URL: ator.su›storage/app/media…osteonekroz.docx (Accessed: 22nd March 2022).

33. Tang C, Wang Y, Lv H, Zhenpeng Guan Z, Jin Gu J. Caution against corticosteroid-based COVID-19 treatment. Lancet. 2020; 395(10239):1759-1760. doi: 10.1016/S0140-6736(20)30749-2